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A B S T R A C T
CHRNA7, encoding the neuronal alpha7 nicotinic acetylcholine receptor (a7nAChR), is highly expressed in the brain, particularly in the hippocampus. It is situated in
the 15q13.3 chromosome region, frequently associated with a Copy Number Variation (CNV), which causes its duplication or deletion. The clinical significance of
CHRNA7 duplications is unknown so far, but there are several research data suggesting that they may be pathogenic, with reduced penetrance. We have produced an
iPS cell line from a single healthy donor's fibroblasts carrying a 15q13.3 CNV, including CHRNA7 in order to study the exact role of this CNV during the
neurodevelopment.
Resource table
Unique stem cell line
identifier
CSSi005-A (3544)
Alternative name(s) of
stem cell line
COL03 cl.C3
Institution Cellular Reprogramming Unit, IRCCS Casa
Sollievo della Sofferenza – Viale dei
Cappuccini, 71,013 San Giovanni Rotondo,
Foggia, Italy
Contact information of
distributor
Jessica ROSATIj.rosati@css-mendel.it
Type of cell line iPSC
Origin human
Additional origin info Age: 38
Sex: Female
Ethnicity: Caucasian/Italian
Cell Source Dermal Fibroblasts
Clonality Clonal
Method of
reprogramming
Non integrating episomal vectors
Genetic Modification NO
Type of Modification N/A
Associated disease N/A
Gene/locus 15q11q13 CHRNA7
Method of
modification
N/A
Name of transgene or
resistance
N/A
Inducible/constitutive
system
N/A
Date archived/stock
date
April 2017
Cell line repository/
bank
N/A
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Resource utility
The generation of 15q13.3 CNV iPSC, including CHRNA7, may be
useful in both scientific and clinical fields, because it allows us, on the
one hand, to study the role of CHRNA7 duplication on the development
of the nervous system, and on the other hand, to eventually develop
targeted therapeutics.
Resource details
The region 15q13.3, including CHRNA7 gene, is a chromosome re-
gion particularly prone to rearrangements, such as microdeletion/mi-
croduplication (CNVs), due to an enrichment of low copy repeat (LCR)
elements (De Jaco et al., 2017). Microdeletion of 15q13.3 has been
found to cause neurological phenotypes with high penetrance, while
gains encompassing CHRNA7 is even more enigmatic, making the ge-
netic counselling problematic because experimental and epidemiolo-
gical data are still controversial (Gillentine et al., 2017a, 2017b). The
influence of CHRNA7 duplication can be studied directly on patients'
cells through induced pluripotent stem cell (iPSCs) technology, facil-
itating the comprehension of its influence on brain development. Our
donor is a subject with a normal working and family life, who has no
dysmorphic features or other physical abnormalities, and no form of
hyperactivity, distractibility, or social impairment. The sole cytogenetic
feature of this donor is the presence of CNV, inherited from her father,
affecting the cytogenetic region 15q13.3. The study was carried out,
with the patient's consent, utilizing cells from a skin biopsy. We re-
programmed the fibroblasts into iPSCs, using non-integrative episomal
vectors containing the reprogramming factors OCT4, SOX2, L-MYC,
KLF4, LIN28, shp53. The clones with Embryonic Stem-like morphology
(Fig. 1A) were characterized in indirect immunofluorescence (IIF) mi-
croscopy using specific antibodies against the surface marker TRA-1-60
and the transcription factor OCT4, confirming their expression: TRA-1-
60 protein is present in cell surfaces and OCT4 protein is evident in the
nuclear compartment of the iPS cells (Fig. 1B). Using qPCR we verified
and confirmed the presence in the clones of endogenous expression of
the pluripotency markers, LIN28, SOX2, OCT4 and L-MYC using, as
negative control, the wild-type fibroblasts (Fig. 1C). After more than ten
passages, we confirmed the suppression of exogenous reprogramming
factor expression to negligible levels by qPCR using, as positive control,
the nucleofected fibroblasts (Fig. 1D). Subsequently, pluripotency ca-
pacity of the iPSCs was tested, differentiating the iPSC both in vitro
through embryoid bodies assay (Fig. 1E) and in vivo through a teratoma
assay (on nude immune-deficient mice; NOD/SCID). The expression
level of the markers of each germ layer was demonstrated, through
qPCR, in the embryoid bodies using, as negative control, the iPSCs
(Fig. 1F). Also in the iPSC-derived teratoma, hematoxylin-eosin images
showed the presence of ectodermal derivatives: neuroepithelial struc-
ture with characteristic melanin deposits, mesodermal derivatives:
adipose tissue, endodermal derivatives: secreting (dashed line) and
batiprismatic lining (arrowheads) epithelia (Fig. 1G). Moreover, we
confirmed that, after more than twenty passages, the iPSC line dis-
played a normal karyotype (46, XX) (Fig. 1H). Short tandem repeat
analysis (STR) showed that the DNA profile of the donor's fibroblasts
was identical to the derived iPSCs (data available from the authors).
qPCR on genomic DNA verified that the CHRNA7 CNV was retained in
the iPSCs (Fig. 1I). All cells tested negative for mycoplasma con-
tamination (Supplementary File S1). These data demonstrate that we
have successfully generated a stable patient specific iPSC line, useful for
studying 15q13.3 interstitial duplication encompassing CHRNA7 at the
molecular level (See Table 1).
Materials and methods
Primary skin fibroblast culture
Skin fragments were cut and plated on a 35mm tissue-culture dish
with Dulbecco's Modified Eagle Medium (DMEM) High Glucose sup-
plemented with 20% FBS, 2mM L-Glutamine, 100 U/ml Penicillin-
Streptomicin and 1× Non-Essential Amino Acids (Sigma Aldrich) and
cultured for 30 days to allow fibroblasts to grow out. Fibroblasts were
split by Trypsin once a week, seeding 2*105 cells into a 100mm dish.
Cellular reprogramming
Approximately 1× 105 fibroblasts were nucleofected with 4D-
Nucleofector™ X unit (Lonza), using P2 primary cell nucleofector kit
and FF113 program. A mix of three pCXLE-based episomal vectors were
used: pCXLE-hOCT4-shp53, pCXLE-hUL and pCXLE-hSK (Addgene).
Cells were cultured in fibroblasts medium for 6 days. On day 7, cells
were plated on Matrigel (Corning) coated dishes (BD Biosciences) in
NutristemXF medium (Biological Industries). The emerging iPS colonies
were selected according to their hESC-like colony morphology and
expanded under feeder-free conditions. Both fibroblasts and iPSCs were
Table 1
Characterization and validation.
Classification Test Result Data
Morphology Photography Normal Fig. 1panel A
Phenotype Qualitative analysis Staining of pluripotency markers: Fig. 1panel B
immunofluorescence OCT4 (green)
TRA-1-60 (red)
Quantitative analysis: qPCR Expression of pluripotency markers: Fig. 1panel C
LIN28, SOX2,
L-MYC, OCT4
Genotype Karyotype (G-banding) and resolution 46XX, Resolution 450–500 Fig. 1panel H
Identity Microsatellite PCR (mPCR) OR STR
analysis
N/A N/A
19 loci tested; all matched Data available with the authors
Mutation analysis (IF APPLICABLE) qPCR Increased copy number Fig. 1panel I
Southern Blot OR WGS N/A N/A
Microbiology and virology Mycoplasma Mycoplasma testing by N-Garde Mycoplasma PCR kit
(EuroClone): Negative
Supplementary Figure S1
Differentiation potential In vitro: embryoid body formation Embryoid bodies. Fig. 1panel E
Expression of genes in embryoid bodies: Fig. 1panel F
NESTIN, PAX6, SOX1, T, EOMES, FOXA2,GATA4, SOX 17.
In vivo: teratoma formation Proof of three germ layers formation: Ectoderm, Mesoderm,
Endoderm
Fig. 1panel G
Donor screening (OPTIONAL) HIV 1+2 Hepatitis B, Hepatitis C N/A N/A
Genotype additional info (OPTIONAL) Blood group genotyping N/A N/A
HLA tissue typing N/A N/A
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cultured in 5% CO2 at 37 °C. The iPSC colonies were mechanically-
detached and amplified once a week, the split ratio of iPSCs was usually
1:6. N-Garde Mycoplasma PCR kit (EuroClone) was used to verify the
absence of mycoplasma contamination.
Immunofluorescence staining
Cells were fixed using 4% paraformaldehyde for 20min at room
temperature and blocked in PBS containing 20% Normal Goat Serum.
0.1% Triton X-100 was used for 30min for only OCT4 staining. Next,
primary antibodies, listed in Table 2, diluted in 5% BSA, were added
and incubated O/N at 4 °C. After washing, Alexa-Fluor-conjugated
secondary antibodies were added for 1 h at room temperature. Cellular
nuclei were counterstained with Hoechst. Microphotographs were
taken using a Nikon C2 fluorescence microscope.
RNA extraction and reverse-transcription
Total RNAs were isolated using TRIzol reagent (Life Technologies)
according to manufacturer's instructions. cDNA was synthesized using
High Capacity cDNA Reverse Transcription Kit (Applied Biosystems).
Real-time PCR (qPCR)
qPCR was performed on cDNA using SYBR Green primers for plur-
ipotency markers and TaqMan primers for differentiation markers
Fig. 1. Characterization of COL03 iPSC.
A. COL03 iPSC colonies morphology B. Immunofluorescence staining shows expression of pluripotency markers: OCT4 (green), TRA-1-60 (red), cell nuclei with
HOECHST (blue). C. qPCR analysis for pluripotency markers verified the expression levels of endogenous transcripts in COL03 iPSC. This experiment was repeated
twice in triplicate using independently prepared cDNAs. D. qPCR analysis for transgenes transcripts, after 10 passage, in COL03 iPSC compared to nucleofected
fibroblasts. This experiment was repeated twice in triplicate using independently prepared cDNA. E. COL03 EBs in floating condition. F. qPCR analysis of all three
germ layer markers (Ectoderm, Mesoderm and Endoderm) from COL03 Embryoid Bodies. Data denote actin-normalized fold changes relative to undifferentiated
parental iPSC. G. Histological sections of all three germ layer (Ectoderm, Mesoderm and Endoderm), derived from teratoma stained with hematoxylin and eosin. H.
iPSC karyogram shows normal ploidy of COL03 female subject. I. qPCR analysis on genomic DNA verified that the CHRNA7 CNV was retained in the iPSCs.
Table 2
Reagents details.
Antibodies used for immunocytochemistry/flow-citometry
Antibody Dilution Company Cat # and RRID
Pluripotency Markers Rabbit anti-OCT4 1:100 Life technologies (A13998)
Mouse anti-TRA-1-60 1:100 Life technologies (411000)
Differentiation Markers N/A N/A N/A
Secondary antibodies anti-Rabbit AlexaFluor 488 1:10000 Invitrogen (A11034)
anti-Mouse AlexaFluor 555 1:10000 Invitrogen (A21422)
Primers
Sybr Green Primers used for qPCR Target Forward/Reverse sequence (5′-3′)
Exogenous Episomal genes eOCT4 Fwd: CAT TCA AAC TGA GGT AAG GG
Rev: TAG CGT AAA AGG AGC AAC ATA G
eKLF4 Fwd: CCA CCT CGC CTT ACA CAT GAA GA
Rev: TAG CGT AAA AGG AGC AAC ATA G
eLIN28 Fwd: AGC CAT ATG GTA GCC TCA TGT CCG C
Rev: TAG CGT AAA AGG AGC AAC ATA G
eL-MYC Fwd: GGC TGA GAA GAG GAT GGC TAC
Rev: TTT GTT TGA CAG GAG CGA CAA T
eSOX2 Fwd: TTC ACA TGT CCC AGC ACT ACC AGA
Rev: TTT GTT TGA CAG GAG CGA CAA T
Pluripotency Markers (qPCR) OCT4 Fwd: CCC CAG GGC CCC ATT TTG GTA CC
Rev: ACC TCA GTT TGA ATG CAT GGG AGA GC
LIN28 Fwd: AGC CAT ATG GTA GCC TCA TGT CCG C
Rev: TCA ATT CTG TGC CTC CGG GAG CAG GGT AGG
L-MYC Fwd: GCG AAC CCA AGA CCC AGG CCT GCT CC
Rev: CAG GGG GTC TGC TCG CAC CGT GAT G
SOX2 Fwd: TTC ACA TGT CCC AGC ACT ACC AGA
Rev: TCA CAT GTG TGA GAG GGG CAG TGT GC
House-Keeping Genes (qPCR) β-ACTIN Fwd: GGC ATC CTC ACC CTG AAG TA
Rev: GGG GTG TTG AAG GTC TCA AA
Genotyping
Targeted mutation analysis CHRNA7 Fwd: GCAGGAAGTGCTGGCCTATG
Rev: GGTCCAAACTGTGGGCTCC
TaqMan primers used for qPCR Target Forward/Reverse sequence (5′-3′)
Differentiation markers SOX1 Hs01057642_s1
NESTIN Hs04187831_g1
PAX6 Hs00240871_m1
T Hs00610080_m1
EOMES Hs00172872_m1
GATA4 Hs00171403_m1
FOXA2 Hs00232764_m1
SOX17 Hs00751752_s1
House-Keeping Gene βActin Hs 99999903_m1
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(Table 2) in a 7900HT Fast Real-Time PCR system (Applied Biosystem).
Each reaction was performed in triplicate with β-ACTIN gene as re-
ference. 2–ΔΔCT method was adopted to calculate the relative expression
levels.
The same method was used to confirm the presence of CHRNA7
duplication on DNA extracted from iPSC line using column-based ex-
traction kit (DNeasy Blood & Tissue it; QIAGEN, Hilden, Germany).
DNAs extracted from blood and previously tested negative by SNP-array
were used as controls. TERT gene was used as a reference. Data analysis
was performed as described in Carbone et al. (2008).
Teratoma formation
Approximately 3× 106 cells were detached using Dispase (Gibco).
Cellular suspension was collected at 800 rpm for 5min and then re-
suspended in 100 μl of Matrigel. Cells were injected into the right flank
of nude immune-deficient mice (NOD/SCID) following ethical guide-
lines. Teratomas formed in 4–8weeks. Upon removal, tumors were
histologically analyzed to check for their in vivo differentiation capacity
into derivatives of all three germ layers: ectodermal, mesodermal and
endodermal.
Embryoid body in vitro differentiation
Mechanically-detached iPSCs were plated in a Petri dish in floating
condition. Nutristem-XF medium was then gradually switched with
DMEM F-12, 20% Knock-out serum replacement (Gibco), 0.1 mM β-
mercaptoethanol, 1× NEAA, 50 U/ml Penicillin-Streptomicin, 2 mM L-
glutamine in 3 days. EBs were cultured in suspension for 14 days,
changing the medium every two days, then pelletted and RNAs were
extracted for qRT-PCR analysis.
Karyotype analysis
Cells were cultured in chamber slides (Thermo Fisher Scientific) and
treated with a 0.1 μg/ml COLCEMID solution (Thermo Fisher Scientific)
for 60min at 37 °C. Metaphases were obtained by adding 30mM KCl in
10% FBS at 37 °C for 6min and by fixation using cold fresh-made 3:1
ethanol:acetic acid solution. Karyotype analysis was carried out on
GTG-banded metaphases. Fifteen metaphases were counted and three
karyotypes analyzed (450–500 resolution). Only clonal aberrations
were considered, following the ISCN recommendations.
STR analysis
Fibroblasts and iPSCs DNA were extracted by Dneasy blood and
tissue kit (QIAGEN) following manufacturer's suggestions. PCR ampli-
fication of 19 distinct STRs (D13S252, D13S305, D13S634, D13S800,
D13S628, D18S819, D18S535, D18S978, D18S386, D18S390, D21S11,
D21S1437, D21S1409, D21S1442, D21S1435, D21S1446, DXS6803,
XHPRT, DXS1187) was carried out using the QST*Rplusv2 kit
(Elucigene Diagnostics), PCR products were separated on an ABI Prism
3130 DNA sequencer and analyzed by GeneMapper version 4.0
(Applied Biosystems).
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.scr.2018.09.002.
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